Showing results (201-210 of 321) with videos related to
Sort By:
Pageof 33
Kidney International Reports|January 10, 2022
Efficacy of Rituximab in Treatment-Resistant Focal Segmental Glomerulosclerosis With Elevated Soluble Urokinase-Type Plasminogen Activator Receptor and Activation of Podocyte β3 IntegrinMichelle A Hladunewich, Dan Cattran, Sanjeev M Sethi, et al.Annals of Translational Medicine|July 5, 2023
Perturbations in podocyte transcriptome and biological pathways induced by FSGS associated circulating factorsPriyanka Rashmi, Tara K Sigdel, Dmitry Rychkov, et al.Clinical Science (London, England : 1979)|April 6, 2021
Angiotensin II up-regulates sodium-glucose co-transporter 2 expression and SGLT2 inhibitor attenuates Ang II-induced hypertensive renal injury in miceKana N Miyata, Chao-Sheng Lo, Shuiling Zhao, et al.Diabetes|April 21, 2017
Heterogeneous Nuclear Ribonucleoprotein F Stimulates Sirtuin-1 Gene Expression and Attenuates Nephropathy Progression in Diabetic MiceChao-Sheng Lo, Yixuan Shi, Isabelle Chenier, et al.Transplantation|September 16, 2015
Recurrent Primary Focal Segmental Glomerulosclerosis Managed With Intensified Plasma Exchange and Concomitant Monitoring of Soluble Urokinase-Type Plasminogen Activator Receptor-Mediated Podocyte β3-integrin ActivationOliver Staeck, Torsten Slowinski, Ina Lieker, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 21, 2018
Soluble urokinase-type plasminogen activator receptor and incident end-stage renal disease in Chinese patients with chronic kidney diseaseLi Lv, Fang Wang, Liang Wu, et al.Plos One|March 9, 2010
Novel siRNA delivery system to target podocytes in vivoPeter V Hauser, Jeffrey W Pippin, Cora Kaiser, et al.Lipids in Health and Disease|November 5, 2011
Apoptosis, mastocytosis, and diminished adipocytokine gene expression accompany reduced epididymal fat mass in long-standing diet-induced obese miceMehmet M Altintas, Maria A Rossetti, Behzad Nayer, et al.Transplantation|December 1, 2017
Rituximab and Therapeutic Plasma Exchange in Recurrent Focal Segmental Glomerulosclerosis Postkidney TransplantationSami Alasfar, Dany Matar, Robert A Montgomery, et al.Kidney International Reports|November 29, 2023
Prospective Cohort Study of Soluble Urokinase Plasminogen Activation Receptor and Cardiovascular Events in Patients With CKDClaudia Sommerer, Sandra Müller-Krebs, Jennifer Nadal, et al.Pageof 33